pharmaphorum

Vinay Prasad returns to FDA

In a new spin on the concept of the FDA's 'revolving door', Vinay Prasad is back as head of the Center for Biologics Evaluation and Research (CBER), just over a week after he left the role. The word ...
pharmaphorum

Vinay Prasad abruptly departs from the FDA

Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...
MedPage Today

Vinay Prasad, Critic of COVID Measures, Picked as FDA's Top Vaccine Official

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center ...
pharmaphorum

Makary, Prasad set out their vision for the FDA

Top priorities at the FDA in the coming years will include shorter review timelines for drug development, embracing the use of artificial intelligence and big data, and speeding up approvals for ...